Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort.
Joanna KedraAlexandre LafourcadeBernard CombeMaxime DougadosDavid HajageBruno FautrelPublished in: RMD open (2022)
WCE models can identify and quantify the long-term benefit of early csDMARD initiation on 10-year functional and structural outcomes in patients with RA.